Appetite drugs reshape food demand

As GLP‑1 weight‑loss medicines scale, their users report distinct food concerns (greater focus on sugar, carbs and convenience) and slightly different consumption frequencies for produce, meat and dairy. Those modest but systematic differences can prompt food makers and restaurants to redesign portion sizes, reformulate products, and reorient marketing toward low‑sugar, convenience formats. — If GLP‑1 use keeps growing, the drugs could shift food‑industry product mixes, local foodservice offerings, and nutrition‑policy priorities, producing knock‑on effects for agriculture, supply chains and public health guidance.